In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Solvay licenses Pronova Biocare's Omacor

Executive Summary

Solvay Pharmaceuticals (therapeutics within the areas of cardiology, gastroenterology, mental health, and hormone replacements) received a license to market Omacor, a cardiology product from Pronova Biocare (Omega-3 fatty acids), a business unit of Norsk Hydro's Hydro Pronova subsidiary.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies